Our Services
Medical Information
Helpful Resources
Published on: 10/26/2026
Methylprednisolone is a corticosteroid that reduces inflammation and suppresses an overactive immune system, and it is commonly prescribed for asthma flares, allergic reactions, rheumatoid arthritis, lupus, multiple sclerosis relapses, inflammatory bowel disease, and certain skin, eye, and blood disorders. Common side effects include insomnia, mood changes, increased appetite and weight gain, fluid retention, elevated blood sugar, stomach irritation, and a flushed face, while longer use raises the risk of bone loss, infection, and adrenal suppression. Dosing varies widely by condition, and stopping abruptly after extended use can be dangerous, so several important factors should be reviewed below before starting or changing this medication. Because steroids can mask or mimic other problems, and symptoms like swelling, severe stomach pain, or vision changes may signal something more serious, it helps to clarify what you are actually experiencing. If you are unsure whether your symptoms are a medication side effect or a sign of an untreated condition, take a free, instant, online symptom check to understand possible causes and decide on your next steps with more confidence.
Last reviewed for medical accuracy: 10/22/2026
Methylprednisolone is a prescription corticosteroid often used to reduce inflammation, suppress the immune system, and treat a variety of conditions. It mimics the effects of hormones your body produces naturally in the adrenal glands. When your body doesn’t make enough corticosteroids or you need extra doses to control inflammation, methylprednisolone can help.
Methylprednisolone decreases inflammation by:
Because of these effects, methylprednisolone is a versatile medicine for many acute and chronic conditions.
Methylprednisolone can be prescribed for short-term flare-ups or long-term management of inflammatory and autoimmune diseases. Common uses include:
Your doctor will determine the right dose and length of treatment based on your condition, weight, and response to therapy.
Methylprednisolone is available in several forms:
Your doctor may start with a higher dose and gradually lower it, or prescribe a one-time injection followed by tablets.
Most people tolerate short courses of methylprednisolone well. However, you may experience:
These side effects often improve as your body adjusts or when the dose is tapered down.
Longer-term or high-dose use raises the risk of more significant effects. Contact your doctor right away if you notice:
These effects can be serious and may require adjusting or stopping the medication.
If you experience any life-threatening or serious symptoms—such as severe allergic reactions (difficulty breathing, swelling of face/lips), black or bloody stools, chest pain, or signs of infection—seek immediate medical attention.
For less urgent concerns or to track symptoms before your next appointment, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Methylprednisolone can be a powerful tool against inflammation and immune-mediated disorders. By understanding its uses, side effects, and precautions, you can work with your healthcare team to get the most benefit while minimizing risks.
Always speak to a doctor about any serious or life-threatening symptoms, and follow your provider’s instructions closely. If you have questions about your treatment plan or notice changes in your health, don’t hesitate to reach out for professional medical advice.
(References)
* Fernández S, Reaño M, Vives R, Borja J, Daroca P, Canto G, Rodríguez J. 6-Methylprednisolone-induced bronchospasm. Allergy. 1997 Jul;52(7):780-2. doi: 10.1111/j.1398-9995.1997.tb01242.x. PMID: 9265999.
* Kaminsky A, Moreno M, Díaz M, Charas V, Bravo G, Kien C. Anticonvulsant hypersensitivity syndrome. Int J Dermatol. 2005 Jul;44(7):594-8. doi: 10.1111/j.1365-4632.2004.02233.x. PMID: 15985033.
* Yasuda H, Yoshiba S. [Fulminant hepatitis]. Nihon Rinsho. 2007 Oct 28;65 Suppl 8:545-8. PMID: 18074599.
* Saegeman V, Wynendaele W, Kerre S, Dedeurwaerdere F, Van den Driessche M, Moerman J. Transfusion-induced serum sickness. Transfusion. 2009 Feb;49(2):372-45. doi: 10.1111/j.1537-2995.2008.01956.x. 2008 Oct 28. PMID: 18980620.
* Fernández Arenas O, López Lunar E, Gutiérrez García M, Hidalgo Correas FJ, García Díaz B. [Levofloxacin-related Stevens-Johnson syndrome]. Farm Hosp. 2012 Jan-Feb;36(1):53-5. doi: 10.1016/j.farma.2010.11.006. 2011 Apr 22. PMID: 21514868.
* Maneshi A, Ravi S, Salehi MR, Hasannezhad M, Khalili H. Nicolau Syndrome. Arch Iran Med. 2017 Jan;20(1):60-64. PMID: 28112534.
* Tada K, Kurihara Y, Myojo T, Kojima F, Ishikawa Y, Yoshiyasu N, Morimoto M, Ito R, Koyamada R, Yamashita T, Bando T, Mori S, Heike Y. Case report of nivolumab-related pneumonitis. Immunotherapy. 2017 Mar;9(4):313-318. doi: 10.2217/imt-2016-0129. PMID: 28303763.
* De Greef A, Marot L, Yildiz H, Baeck M. Dermatomyositis with anti-TIF1-γ antibodies. BMJ Case Rep. 2018 Oct 7;2018. doi: 10.1136/bcr-2018-227574. 2018 Oct 7. PMID: 30297488; PMCID: PMC6194424.
* Haq MI, Nixon J, Stanley AJ. Imatinib and liver toxicity. BMJ Case Rep. 2018 Dec 7;11(1). doi: 10.1136/bcr-2018-226740. 2018 Dec 7. PMID: 30567202; PMCID: PMC6301445.
* Pérez-Aragón AJ, Díaz-Molina M, Romero-Paniagua MT, Martínez-Cañavate A. [Allergy to methylprednisolone]. Rev Alerg Mex. 2019 Jul-Sep;66(3):386-387. doi: 10.29262/ram.v66i3.639. PMID: 31606026.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.